Next Article in Journal
Mung Bean Peptides Alleviate Dextran-Sulfate-Sodium-Induced Colitis Symptoms in Mice by Protecting the Intestinal Mechanical Barrier and Regulating Gut Microbiota
Previous Article in Journal
Effect of Two-Stage Water Addition on Consistency of Processed Cheese: Physicochemical, Mechanical, Thermal, and Organoleptic Approach
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Non-Animal Hyaluronic Acid from Tremella fuciformis: A New Source with a Structure and Chemical Profile Comparable to Hyaluronic Acid

1
Noivita S.r.l.s., Spin Off of University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy
2
Department for Sustainable Development and Ecological Transition, University of Piemonte Orientale, Piazza Sant’Eusebio 5, 13100 Vercelli, Italy
3
Department of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Guido Donegani 2/3, 28100 Novara, Italy
4
Department of Science and Technological Innovation, University of Piemonte Orientale, Viale Teresa Michel 11, 15100 Alessandria, Italy
*
Author to whom correspondence should be addressed.
Foods 2025, 14(8), 1362; https://doi.org/10.3390/foods14081362
Submission received: 25 February 2025 / Revised: 2 April 2025 / Accepted: 5 April 2025 / Published: 15 April 2025
(This article belongs to the Section Food Physics and (Bio)Chemistry)

Abstract

:
Tremella fuciformis is high in polysaccharides, which have a structure made up of a straight chain of (1→3) α-D-mannan and side chains of glucuronic acid, xylose, and fucose. This study aimed to evaluate whether the non-animal hyaluronic acid extracted from Tremella fuciformis can maintain the chemical and physical characteristics of hyaluronic acid that ensure its biological functionality. Chemical and physical analyses such as hyaluronic content, screening of metals, purity, pH, nuclear magnetic resonance (NMR), Fourier transform infrared spectroscopy (ATR/FTIR), and MALDI-TOF were performed. Chemical characterisation revealed that the most abundant polysaccharide in the extract was hyaluronic acid, accounting for ca. 87.76%, with a molecular weight above 2000 kDa. In addition, ATR/FTIR and NMR spectroscopy and MALDI-TOF analysis confirmed that Tremella fuciformis extract is a source of non-animal hyaluronic acid. In summary, every molecular attribute examined played a significant role in determining the functional qualities of the extract, indicating that a thoughtful choice of extraction technique can enhance its advantages.

1. Introduction

The cultivation of edible mushrooms has a long history in Asia. They are important to diets worldwide as they are rich in nutrients and medicinal benefits [1]. In addition, they possess secondary metabolites such as terpenes and proteins with antimicrobial, antiviral, antitumor, antithrombotic, and immune properties [2]. Mushroom-derived polysaccharides, particularly β-glucans, are gaining interest among researchers and food manufacturers for their antioxidant, antidiabetic, anticarcinogenic, and immunomodulatory effects and multiple health benefits [3].
Tremella fuciformis Berk, the fruiting body of the basidiomycete fungus Tremella, has been used for thousands of years in traditional Chinese medicine for its remarkable therapeutic properties in skin care, immune system strengthening and disease prevention. The polysaccharide of Tremella fuciformis (TFPS), identified as the main bioactive component of Tremella fuciformis present in the fruiting body, spores, mycelia, and fermentation liquor, shows multiple physiological and health-promoting effects, such as immune function enhancement, antitumor, antioxidation, anti-ageing, hypoglycaemia, hypolipidemia, neuroprotection, and other effects [4]. Tremella fuciformis is naturally rich in polysaccharides, which may contribute to anti-ageing and antioxidant effects due to its ability to prevent cellular damage caused by free radicals [5]. The chemical structure of polysaccharides consists of a linear backbone of (1→3) α-D-mannan with side chains composed of glucuronic acid, xylose and fucose. The estimated ratio of mannose, fucose, xylose, and glucuronic acid in Tremella fuciformis is 9:1:4:3, with glucuronic acid accounting for 17.6% of the polysaccharide content [6,7]. Moreover, the acid polysaccharide derived from the fruiting body of Tremella fuciformis through hydrothermal treatment is identified as a high molecular weight polysaccharide exceeding 106 Da, primarily comprising mannose, glucuronic acid, glucose, xylose, and fucose (with a mass ratio of monosaccharides at approximately 6.8:1:0.15:1.5:0.6). Especially, different experimental conditions can result in various fractions of TFPS, so that TFPS is a mixture of different polysaccharides with molecular weights between 5.82 × 105 Da and 3.74 × 106 Da. The characterised chemical structure of TFPS consists of a linear backbone (1→3) of α-D-mannose with highly branched side chains of β-D-xylose, α-D-fucose and β-D-glucuronic acid [8]. Structural modification of polysaccharides primarily involves exploiting their inherent reactive groups, such as the hydroxyl, carboxyl, and amine groups, to introduce new functional groups through chemical methods. The process of chemically modifying polysaccharides encompasses various techniques, including acetylation, carboxymethylation, sulfation, phosphorylation, alkylation, and selenisation [9]. The most common chemical modification of TFPS is sulfation, which has improved its biological activities and water solubility [10].
The conservation of the fresh fruiting body of Tremella fuciformis poses challenges due to its susceptibility to browning, changes in olfactory characteristics, and deterioration, which may transpire even under refrigeration. Consequently, the assurance of bioactive compounds’ stability and aroma regulation are critical concerns within the industry. The investigation undertaken by Lin et al. [11] analysed the proportions and variations in the composition of Tremella fuciformis polysaccharides produced via an array of desiccation methodologies, including freeze-drying, cold air drying at 18 °C, and hot air drying at 50 °C. Furthermore, their study explored the kinetic parameters of the endothermic reactions pertinent to Tremella fuciformis polysaccharides employing diverse thermal analytical techniques, such as differential scanning calorimetry [12] and thermogravimetry [13], which enabled discernment of the characteristics of additives suitable for incorporation in cosmetics, health food products, biomaterials, and various other applications. Also, the growth of Tremella fuciformis is subject to the influence of multiple elements (such as temperature, light, and water), leading to potential fluctuations in the quality of polysaccharides. Interestingly, employing the submerged fermentation technique effectively regulates these delicate factors [14]; thus, manipulating fermentation parameters can impact the polysaccharide output of Tremella fuciformis [15]. In general, the isolation of polysaccharides from marine and terrestrial sources includes enzymatic hydrolysis [16]. Still, in the case of Tremella fuciformis, polysaccharides are generally extracted by subjecting pulverised fruiting bodies to a prolonged period of stirring in hot water [17,18]. The method of polysaccharide extraction from Tremella fuciformis, as outlined in the extant literature, involves initial immersion of the dried mushroom in water, followed by a series of subsequent mixing, heating, cooling, and centrifugation steps [19]. Nonetheless, the extraction process has the capacity to exert an influence on such factors as the content, quality and chemical and physical composition of the polysaccharides [20].
The prevailing methodology for isolating TFPS is characterised by ethanol precipitation; however, this method is associated with extended extraction times and considerable depletion of polysaccharides. Additionally, the polysaccharides obtained are often tainted with various contaminants, such as pigments, proteins, and nucleic acids, which necessitates further purification procedures [21]. The fundamental objective of TFPS extraction is to optimise extraction efficiency while preserving the integrity of the polysaccharide’s active structure. Consequently, the selection of an appropriate extraction technique is of paramount importance. Various extraction methodologies significantly influence polysaccharides’ efficacy, physicochemical characteristics, and biological activities [22]. The scientific literature indicates that the extraction rate of TFPS can be increased 3–4 times by using two or more extraction methods compared to a single extraction method. For example, repeated freezing and thawing steps combined with the double water phase method are used to extract the TFPS from the fermentation broth, which enabled the removal of most proteins and pigments and increased the extraction rate of the polysaccharide to over 80% [21,23]. After choosing the extraction method, the supernatant is collected by centrifugation or filtration, and the residue is extracted, usually three times. Notably, despite ethanol limitations, the extract is then concentrated to a quarter of its original volume [24] and precipitated using three volumes of absolute ethanol at 4 °C for 24 h. The precipitate is collected by centrifugation and freeze-drying [25] or low-temperature drying [18] to obtain the crude polysaccharide. In the present study, diluting the ethanol as much as possible was preferred to obtain a minimum concentration sufficient to precipitate the extract without altering its structure and content. Furthermore, the ethanol was systematically diluted until its complete removal, signifying an advancement in the extraction process beyond the extant literature [15,26,27].
In summary, a purification process is required at the end of the extraction process to get an extract containing only polysaccharides. The purification process of the unrefined TFPS commonly utilises ion-exchange chromatography to segregate neutral and acidic polysaccharides, with elution performed using water and gradients containing different sodium chloride concentrations. The underlying concept is linked to the equilibrium between ion exchange and molecular weight impacts. Additionally, gel filtration chromatography can segregate polysaccharides based on their molecular weights. Polysaccharides with higher molecular weights facilitate a quicker separation from chromatography columns [28]. Purified polysaccharides can be analysed using high-performance liquid chromatography (HPLC) to determine their purity and molecular weight.
As reported in the literature, they can be analysed by ultraviolet spectroscopy (UV), infrared spectroscopy (IR), gas chromatography (GC), mass spectrometry (MS), and nuclear magnetic resonance (NMR) to determine the structure of polysaccharides [29].
In the present study, the application of a sequential hydrolysis extraction method and ethanol precipitation from a mushroom represents an innovation. Specifically, the innovation is to be able to obtain HA from grinding a mushroom as is without chemical additions, resulting in a high molecular weight HA contrary to what has always been obtained (low molecular weight HA). Therefore, based on these premises, the purpose of the following study was to characterise the hyaluronic acid (HA) extract derived from Tremella fuciformis through chemical and physical analyses to confirm the presence and purity of hyaluronic acid and determine its structural properties. This study was undertaken to complement previous observations at the joint level [30] and enhance the extract’s chemical and physical valence by supporting its biological effects.

2. Materials and Methods

2.1. The Materials and Chemical Reagents

Non-animal hyaluronic acid was obtained from White Tremella (Silver Ear), a traditional foodstuff with medicinal applications in China [4]. The production process involves several steps necessary to get a final extract (named GreenIuronic®) and includes a new technology based on patents N° WO/2020/245809 and N° WO2021/250566A1 from Vivatis Pharma GBHE, Grüner Deich 1–3, 20,097 Hamburg, Germany. The process involves extraction, purification, and refining with an alcohol solution, sieving, and crushing (Figure 1). The resulting powder is packed, tested for metals, and stored [31,32]. All chemicals and reagents used in this study were purchased from Merck Life Science (Rome, Italy), MilliporeSigma (Burlington, MA, USA), and Sigma-Aldrich (Darmstadt, Germany). In addition, all chemicals and reagents were of analytical grade.

2.2. Non-Animal Hyaluronic Acid Extraction from Tremella fuciformis

The methodology employed for extracting non-animal hyaluronic acid from Tremella fuciformis constitutes a multi-faceted process; the extraction procedure, under patent, is delineated into distinct stages [31]. The preliminary phase involves identifying Tremella fuciformis fungi deemed suitable for maturation and growth, which will be utilised in the extraction endeavour. Following this initial phase, the selected fungal biomass underwent a fragmentation and pulverisation step, obtaining a 20 mesh powder, and then underwent an enzymatic hydrolysis step conducted at 95 °C for 3–10 h using an aqueous solvent infused with proteolytic enzymes such as amylase, pectinase, and cellulase. Resulting in a 200 mesh product, which was then concentrated by creating a vacuum. At the end of the extraction and concentration phases, a precipitation phase was carried out for 4 h using food-grade ethanol diluted to 80% in a ratio of 3:4; once the precipitate was formed, the precipitating agent was removed by heating to below room temperature (about 15 °C) and diluting with water. Finally, the extract was concentrated and dried to obtain non-animal hyaluronic acid. A schematic representation of the extraction process is shown in Figure 1.

2.3. Total Polysaccharides Content Colorimetric Assay

6 mg of raw sample (Tremella fuciformis) was dissolved in 1 mL of deionised water (carbohydrate solution) and mixed with 1 mL of 5% (w/w) aqueous phenol solution (phenol, Merck Life Science, Rome, Italy) prepared immediately before the use in a test tube. Subsequently, 5 mL of concentrated sulfuric acid (99%, Merck Life Science, Rome, Italy) was added rapidly to the mixture. After allowing the test tubes to stand for 10 min, they were vortexed for 30 s and placed for 20 min in a water bath at room temperature for colour development. Then, light absorption at 490 nm was recorded on a spectrophotometer (Infinite 200 Pro MPlex, Tecan, Männedorf, Switzerland). Reference solutions (6 mg/mL of saccharose, Merck Life Science, Rome, Italy) were prepared identically to the above, except that the 2 mL aliquot of carbohydrate was replaced by bidistilled water. The phenol (Merck Life Science, Rome, Italy) used in this procedure was redistilled, and 5% phenol in water (w/w) was prepared immediately before the measurements. The calibrations were performed using standard solutions prepared from the corresponding high-purity sugar saccharose. The UV was programmed to produce a calibration curve with the following concentrations: 10, 20, 30, 40, 50, 60, and 70 mg/L. The solution was measured in triplicate and expressed as mean (%w/w) ± SD [33].

2.4. Hyaluronic Acid (HA) Content Colorimetric Determination

The samples’ hyaluronic acid (HA) content was determined as reported in the literature [30,34] with a few modifications. 6 mg of raw material (Tremella fuciformis) was dissolved in 1 mL of deionised water, and 10 µL of resuspended samples were displaced in new Eppendorf tubes and diluted with 190 µL deionised water. Then, 1.2 mL of sulfuric acid (Merck Life Science, Rome, Italy) and 0.0125 M tetraborate (Merck Life Science, Rome, Italy) were displaced in Eppendorf tubes containing diluted samples, shaken for 20 s, and then boiled at 100 °C for 5 min. After cooling on ice, 20 µL of 0.15% hydroxydiphenyl (Merck Life Science, Rome, Italy) (dissolved in 0.5% NaOH, Merck Life Science, Rome, Italy) was added and stirred; successively, 100 µL of each sample was placed in a 96 multi-well plate, and absorbance at 340 nm was measured using a spectrophotometer (Infinite 200 Pro MPlex, Tecan, Männedorf, Switzerland). The data were compared to a calibration curve generated using glucuronic acid (standard curve range from 0 to 6000 µg/mL, Merck Life Science, Rome, Italy). The results were expressed as mean (%w/w) ± SD.

2.5. Water Content Determination

The analysis was performed following the Karl Fischer method [35]. The percentage of water concentration in the sample was determined by KF titration using a Mettler Toledo model C20 coulometric KF titrator and Aquastar CombiCoulomat fritless methanol solution (MilliporeSigma, Burlington, MA, USA) as the reagent. The KF titrator was qualified for use before analysis using Hydranal® Water Standard 10.0 (Honeywell Fluka, Mexico City, Mexico).

2.6. N-Acetyl-Glucosamine Content Determination

The HPLC system (Agilent, Santa Clara, CA, USA) separated and detected Acetylgalactosamine (GalNAc) and N-acetylglucosamine (NAG). A C18 Luna column (Phenomenex, Castel Maggiore, BO, Italy) was used to separate GalNAc and NAG at 30 °C in a column oven. The mobile phase consisted of water and methanol (35:65, v/v) and was pumped at a 0.3 mL/min flow rate. The isocratic mode was applied. The injection volume was 20 µL. The reading wavelength was 195 nm. GlcNAc and NAG working standard solutions were prepared daily from 25 to 200 µg/mL and 10 to 160 µg/L, respectively, by diluting in the mobile phase [36].

2.7. Screening of Metals and Sodium Content

Metals and sodium were analysed using the United States Pharmacopeia (USP) method 233 [37]. The procedure for determining metal concentrations aims to detect elemental impurities, which are generally detectable by inductively coupled plasma mass spectrometry (ICP-MS). A 100 mg sample was weighed into a 50 mL tube, dissolved in 5 mL ultrapure water, and sonicated for 15 min. After sonication, the volume was adjusted to 50 mL by adding ultrapure water. Thus, the solution was analysed using iCAP™ PRO XP ICP-OES spectrometer (Thermo Fisher Scientific Inc., Waltham, MA, USA).

2.8. Experimental Protocol to Determine Molecular Weight

The molecular weight of non-animal hyaluronic acid was determined using 1% agarose gel, following the method reported in the literature for HA determination [30,38], with a few modifications. Briefly, 0.3 g agarose (Merck Life Science, Rome, Italy) was dissolved in 30 mL of TAE buffer (48.5 g tris base, 11.4 mL acetic acid, and 0.5 M ethylenediaminetetraacetic acid, EDTA, pH 8; all substances were purchased from Merck Life Science, Rome, Italy). The solution was heated for 30 s in a microwave at high power. The gel was poured into the holder and solidified before performing a pre-run at 100 V for 45 min, using the Mini-Sub Cell GT System (Bio-Rad, Hercules, CA, USA). In the meantime, samples were prepared by dissolving 3 mg of raw samples in 1 mL of TAE buffer 1×. Before running the gel, 16 µL of the resuspended sample was put in a new Eppendorf tube, and 4 µL of loading buffer (0.2% Bromophenol Blue, 1 mL of TAE 1×, and 8.5 mL of glycerol, which were purchased from Merck Life Science, Rome, Italy) was added to each sample and the molecular weights (10 µL of Select-HA HiLadder, Echelon Biosciences, Tebu-Bio Srl, Magenta, Italy). The samples were run at 100 V until they reached 1 cm from the end of the gel. Then, the gel was hydrated in ultrapure water for 24 h at room temperature in agitation, and then the gel was placed in 30% ethanol with 0.015% Stains All dye (Merck Life Science, Rome, Italy) for 24 h in the dark. The gel was decoloured for 30 min in ultrapure water in the dark before image acquisition using ChemiDoc™ Touch Imaging System (Bio-Rad, Hercules, CA, USA). The image obtained was analysed by Image Lab 3.0 software (Bio-Rad Hercules, CA, USA).

2.9. Particle Size Distribution

The test product was solubilised in an organic solvent and analysed by HPLC (Agilent, Santa Clara, CA, USA) with a GPC detector (Agilent 1260, Agilent, Santa Clara, CA, USA). The molecular weight assessment was performed by analysing reference materials at different molecular weights, in particular 194 Da, 1010 Da, 8500 Da, 19,330 Da, 141,700 Da, 427,500 Da, 1,044,000 Da, 1,250,000 Da, and 2,500,000 Da.

2.10. pH Determination USP 791

Following the standard protocol, one gram of the sample was weighed, dissolved in 100 mL of ultrapure water, and continuously agitated at room temperature. Once the material was fully dissolved, a pH assay was performed while the sample was continuously stirred [39]. The pH50 VioLab pH meter with XS 201T DHS digital electrode and integrated temperature sensor was used for detection (range: pH: 0.00–14.00; mV: 1000; temperature: 0–100.0 °C).

2.11. Purity

The purity of non-animal hyaluronic acid was determined by HPLC (HPLC instrument from Shimadzu, Kyoto, Japan) analysis using the method reported in the literature for HA detection [30]. Briefly, 20 μL of TRIS buffer (3.0 g TRIZMA base, 4.0 g sodium acetate trihydrate, 1.46 g sodium chloride, and 50 mg crystalline bovine serum albumin dissolved in 100 mL of 0.12 M HCl, pH 7.3 with 6 M HCl; all substances were purchased from Merck Life Science, Rome, Italy), 30 μL of chondroitinase AC solution (diluted to 10 U/mL with water), and 20 μL of the sample solution test (200 mg of raw material dissolved in 100 mL of ultrapure water) were pipetted into a conical 1.5 mL vial. The vial was placed in a warm water bath at 37 °C for 3 h. After cooling at room temperature, the sample was diluted to 1 mL by adding 930 μL of mobile phase A, and the mixture was analysed by HPLC-UV and HPLC-HRMS systems. A control solution was prepared by replacing the enzyme aliquot with TRIS buffer.
Specifically, for the HPLC-UV method, a column from Phenomenex Synergi Polar 4 µm 150 × 4.6 mm was preceded by a Security Guard Polar and kept at room temperature. The mobile phase A was composed of 340 mg of tetrabutylammonium bisulfate dissolved in 1000 mL of water HPLC grade, while the mobile phase B was composed of 340 mg of tetrabutylammonium bisulfate dissolved in 330 mL of water HPLC grade, then after the solution is at room temperature, brought to 1000 mL with acetonitrile. For the reading, a volume of injection of 30 µL was used, a flow rate of 1.1 mL/min, and a wavelength of 240 nm. The gradient elution program used is reported in Table A1 (Appendix A).
On the other hand, for the HPLC-HRMS method, a column from Phenomenex Synergi Polar 4 µm 150 × 2.0 mm was preceded by a Security Guard Polar and kept at room temperature. The mobile phase A comprised 0.1% formic acid in ultrapure water, while the mobile phase B comprised 0.1% formic acid in acetonitrile. For the reading, a volume of injection of 5 µL was used and a flow rate of 0.200 mL/min. The gradient elution program implemented is reported in Appendix A (Table A2).

2.12. NMR Analysis

A solid-state 13C magic angle spinning NMR spectrum was acquired on a Bruker Avance III 500 spectrometer (Fällanden, Switzerland) equipped with a wide bore 11.75 T magnet, operating at frequencies of 500.13 MHz for 1H and 125.77 MHz for 13C. A 4 mm triple-resonance probe with magic angle spinning (MAS) was used in all experiments. The samples were packed on a Zirconia rotor and spun at an MAS rate of 11–15 kHz. For the 13C cross-polarization (CP) MAS experiments, 55 and 28 kHz RF fields were used for initial proton excitation and decoupling, respectively. During the CP period, the 1H RF field was ramped using 100 increments, whereas the 13C RF fields were maintained at a constant level. The protons were decoupled from the carbons during the acquisition using a two-pulse phase-modulated decoupling method. A moderate ramped RF field of 62 kHz was used for spin locking, while the carbon RF field was matched to obtain the optimal signal [40]. The relaxation delay between accumulations was 5 s, and the CP contact time was 0.5 ms. All chemical shifts are reported using a δ scale and are externally referenced to tetramethylsilane at 0 ppm.

2.13. Attenuated Total Reflection (ATR) Fourier Transform Infrared Spectroscopy (FTIR) Analysis

The analysis was performed using a Bruker Alpha II instrument (Bruker Optics, Rosenheim, Germany) equipped with an ATR accessory with a monolithic diamond crystal and a DTGS detector. The instrument operated in the 4000–450 cm−1 range at a resolution of 4 cm−1. OPUS Software (Release 8.7) was used to process the ATR-FTIR spectra.

2.14. Polysaccharides Spectrum by Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight (MALDI-TOF)

To verify a correct enzymatic extraction process, samples from different stages were analysed; in particular, 3.0 µL of raw material (10 mg of raw material dissolved in 1 mL of ultrapure water) were mixed with 3.0 µL of matrix solution (20 mg/mL 2,5-Dihydroxybenzoic acid dissolved in 30:70 (v/v) acetonitrile: 0.1% TFA in water, 1 mM NaCl; all substances were purchased from Merck Life Science, Rome, Italy). 0.5 µL of each mix was spotted on a ground steel MTP 384 target plate (Bruker Daltonics GmbH, Bremen, Germany) in triplicate and let to dry at room temperature overnight. MALDI-TOF spectra were acquired by an Ultraflextreme mass spectrometer (Bruker Daltonics GmbH, Bremen, Germany) equipped with a Smart-beam 2 Nd: YAG laser operating at 355 nm, using FlexControl software (version 3.3, Bruker Daltonics GmbH, Bremen, Germany). Samples were analysed linearly, and positive ion acquisition was achieved in a mass-to-charge ratio of 300–5000 m/z. The mass spectra obtained are 6000 shots for each sample; the random walk feature with partial sample mode was activated. This analysis was performed according to the data reported in the literature [41,42].

2.15. Statistical Analysis

The experimental procedures were conducted with three independent analyses, with the resulting data presented as mean values accompanied by their respective standard deviations. The statistical significance of the multiple averages was assessed using the variance analysis methodology using the statistical software Prism GraphPad 9.5.0. The statistical significance threshold was set at p < 0.05.

3. Results

3.1. Chemical Characterisation

3.1.1. Analyses of Non-Animal Hyaluronic Acid Content

Table 1 delineates the findings on the concentrations of sugars/polysaccharides, HA, uronic acid, N-acetylglucosamine (NAG), and water present within the non-animal hyaluronic acid derived from Tremella fuciformis. What is evident from the data (Table 1) is that the extract obtained from Tremella fuciformis is significantly enriched in polysaccharides, as the concentration of these compounds within the extract is remarkably high, constituting approximately 90.6% of the total weight of the extract. This observation implies that, once the extraction protocol is refined, it may be a pivotal method for obtaining polysaccharide extracts with exceptionally high yields. Upon establishing that the extract resulting from the extraction procedure was indeed a polysaccharide extract from Tremella fuciformis, it became imperative to elucidate the characteristics of the polysaccharides. The analysis revealed that of the 90.6% polysaccharides present in the extract, approximately 87.8% were identified as HA, indicating that the polysaccharide extract acquired from Tremella fuciformis is notably abundant in HA. Subsequently, the uronic acid content was less than 3% residual, signifying an advantageous yield from the extraction process. The scientific literature corroborates this finding, since Li and colleagues conducted a study to evaluate the effect of different drying methods on the chemical composition and physical properties of Tremella fuciformis extracts. Specifically, it was observed that a low-temperature drying process (freeze-drying) could maintain the uronic acid content (2.24%) at levels comparable to that of the undried mushroom (2.87%) [43]. Similarly, the NAG content was also evaluated. The reported data demonstrate a minimal presence of NAG within the extract, which was found to be less than 0.1%. Finally, the water content within the extract was determined, which was observed to be about 7.6% of the total extract.
In conclusion, the results obtained from the analysis of the non-animal hyaluronic acid from Tremella fuciformis showed a high concentration of polysaccharides, particularly HA, which constituted about 87.8% of the total polysaccharides in the extract. These data suggest that the extraction process permits powder extraction of hyaluronic acid or similar molecules. Furthermore, the low presence of NAG residues and the relatively low water content indicate a good efficiency of the extraction process, making this extract a promising candidate for industrial applications.

3.1.2. Analysis of Metals and Sodium Content

Metals including arsenic, cadmium, cobalt, chromium, copper, lead, mercury, zinc, nickel, tin, selenium, iron, magnesium, and manganese may be present within the sediments of mushroom cultures, consequently influencing their overall composition. Hence, rigorous screening for heavy metals was conducted to eliminate the possibility of contamination in the non-animal hyaluronic acid extract from Tremella fuciformis. In Table 2, all analytical data pertinent to the metals are presented, revealing either the absence of heavy metals (arsenic, cadmium, cobalt, chromium, mercury, lead, copper, and zinc) or their presence in negligible quantities, alongside a minimal occurrence of non-heavy metals (nickel, iron, manganese, selenium, and tin), with the singular exception of magnesium, which was identified at a concentration of 99.8 ppm. Furthermore, the sodium content was analysed to ascertain that the extracted substance is not a salt derivative. The findings indicated that sodium levels comprised 1.77% of the extract in solution, thereby corroborating that the extract procured is indeed HA and not a derivative salt (e.g., Sodium Hyaluronate).

3.1.3. Molecular Weight Determination

As illustrated in Figure 2A, the extract exhibited a molecular weight of over 2000 kDa, indicating that it resembles a high molecular weight variant of HA. As depicted in the sample chromatogram (Figure 2B), the results across all assessments revealed that the particle size distribution was recorded at Mn 5185 kDa and PD 2.364, supporting the data observed by agarose gel.

3.1.4. Purity and pH Analyses of Non-Animal Hyaluronic Acid

To understand whether non-animal hyaluronic acid was classifiable as fully fledged HA, purity was assessed by HPLC analysis to understand whether there were also sulfated polysaccharide forms. The analysis (Figure 3) revealed that the non-animal hyaluronic acid corresponded to disaccharide ΔDi-HA produced by enzymatic hydrolysis of Tremella extract with chondroitinase AC. The identity of this disaccharide was verified by comparison with the reference standard ΔDi-HA and the detection of protonated and sodium-plated positive ions in its mass spectrum. The same analysis also demonstrated the absence of chondroitin monosulfates 4 and 6, eluted at 6.25 and 5.35 min, respectively.
pH is a pivotal parameter that can considerably influence a variety of functional properties of a molecule, including colour, taste, and texture. In this study, the pH of Tremella fuciformis extract was measured and evaluated upon its dissolution in an aqueous solution. Furthermore, to maintain structural integrity, the HA must possess a pH exceeding 4 and fall below 11 when dissolved in solution; otherwise, the HA may undergo degradation. Based on the analysis conducted by the USP 791 methodology (Table 3), the non-animal hyaluronic acid exhibits a pH value approximating 6.5 pH units, which resides within the acceptable range for application (5.5–7.5).

3.2. Physical Characterisation Results of Non-Animal Hyaluronic Acid

To verify that non-animal hyaluronic acid was indeed of quality following all extraction steps, the following experiments were performed to characterise the structure of this extract: NMR analysis, IR/ATR spectrum, and MALDI-TOF analysis [41,44].

3.2.1. NMR Analysis of Non-Animal Hyaluronic Acid

Solid-state NMR spectroscopy is a valuable tool for investigating the molecular structure, composition, and functional groups of polysaccharides in solid state. By studying 13C CPMAS NMR, it is possible to detect important structural elements and 3D arrangements of polysaccharide chains [45]. In the 13C CPMAS spectrum (Figure 4) of non-animal hyaluronic acid, 13C peaks appeared very broad due to carbohydrate polymer chains in a disordered amorphous state. The methyl carbon appeared at around 16.5 ppm while the carbonyl carbon resonance was around 175.5 ppm. Moreover, the very broad peak observed between δ = 55–85 ppm is linked to the different 13C sites in the disaccharides, which consist of glucuronic acid and N-acetyl-glucosamine monomeric units. The disaccharide’s C1 and C1’ peaks appeared at around 101 ppm. The polymer chains of the disaccharides are linked via the glycosidic bonds forming interconnected networks constituting several randomly ordered three-dimensional arrangements. The broad downfield peak detected in the 1H MAS NMR spectrum (Figure 4) confirmed the extended intra- and interchain hydrogen bonds responsible for the disordered arrangements.
The 13C chemical shifts and number of peaks for non-animal hyaluronic acid are similar to those reported in the literature. The only difference is related to the 13C NMR peak resolution. However, the 13C NMR spectra reported in the literature were for animal-derived sodium hyaluronate, while here we report the hydrated form of non-animal hyaluronic acid [46,47].

3.2.2. ATR-FTIR Spectroscopy

The ATR-FTIR spectrum of the studied extract was measured to validate the structural and compositional data of non-animal hyaluronic acid. Attenuated Total Reflectance (ATR) is a widely used sampling method in FTIR spectroscopy, employing total internal reflection to generate an evanescent wave that penetrates the sample surface. This wave allows detailed data acquisition on molecular composition and structure. ATR’s popularity stems from its versatility in analysing both solid and liquid samples in their native state, streamlining the analysis of a wide range of substances. The results showed that the spectrum (Figure 5, curve a) is fully compatible with the structure of hyaluronic acid in hydrated form, with the most significant bands assigned as follows. The broad band in the 3600–3000 cm−1 range (peak at 3295 cm−1) is due to hydrogen-bonded O-H and N-H stretching modes; signals at 2923 and 2873 cm−1 are assigned to asymmetrical and symmetrical stretching modes of C-H groups in CH, CH2, and CH3 groups. In the low frequencies’ region, bands at 1604 and 1412 cm−1 are ascribed to the νas and νsym of COO groups, respectively; the shoulder at 1645 cm−1 is due to the bending mode of water and the amide I band. The signals at 1133, 1048, and 1027 cm−1 are assigned to C-O-C in glycosidic groups, C-O (exocyclic), and C-OH groups, respectively. For the sake of comparison, the ATR-FTIR spectrum of standard HA is reported (Figure 5, curve b). In summary, it was observed that apart from some differences in relative intensities (related to possible differences in chain length and particle size of the sample), the same peaks identified in the non-animal hyaluronic acid may be traced back to what is known in the literature for standard HA [48,49,50].

3.2.3. MALDI-TOF

MALDI-TOF mass spectrometry was used to analyse different steps during non-animal hyaluronic extract preparation. The characterisation of HA with MALDI mass spectrometry presents some challenges due to its chemical properties. HA has poor ionisation efficiency, and optimising sample preparation can improve characterisation. However, direct analysis of highly polydisperse mixture of long HA fragments (>10 kDa) is complicated due to short fragments suppressing high mass species ions. In our analysis, the final extract was compared with an extract of non-animal hyaluronic acid before extraction (designated as YEF) and with an intermediate extract (designated as YET). The findings illustrated in Figure 6 and Table A3 (reported in Appendix B) demonstrate variances in the peaks population. Elevated peaks characterise the initial pulverised YEF in comparison to the intermediate YET. In both samples (YEF and YET), some peaks corresponding to HA oligomers were detectable, in detail 1516.55 and 1515.37 corresponding to 8 mer; 2650.58 and 2649.02 corresponding to 14 mer. The molecular weight difference between the high-intensity peaks is quantified at 162 Da, corresponding to a single glucan unit. The minimal difference is quantified at 17 Da, attributed to chlorine adducts or hydroxyl groups. Another way to interpret the MALDI-TOF spectra is by observing that glucans were detected as sodium ions adducts ([Glcn + Na]+) displaying a peak-to-peak mass differential of 162 Da, which is consistent with the repetitive unit of β-(1→3) glucan [32]. Similar findings have been documented previously [49]; the fruiting body of Tremella fuciformis is constituted of (1→2)- and (1→4)-mannose as well as (1→3)-linked glucans [21]. Based on the data obtained, it can be discerned that there is a progressive and pronounced decrease in the number of peaks from the raw material YEF to the extract of non-animal hyaluronic acid. Indeed, a molecular weight disparity is observable between the high-intensity peaks corresponding to a sugar unit, specifically glucan. This substantiates the efficacy of the extraction and purification methodology employed to obtain the non-animal hyaluronic acid, which is more prominently present in the sample preceding digestion (YEF sample) through an enzymatic process, as represented by an intermediate extract (YET sample). Ultimately, the purified non-animal hyaluronic acid significantly diminishes the number of units discernible as glucan.

4. Discussion

Tremella fuciformis, commonly called snow fungus or silver ear fungus, is an edible medicinal mushroom from the Tremellales order and the Tremellaceae family. It contains various bioactive compounds, including fatty acids, proteins, enzymes, polysaccharides, phenols, flavonoids, fiber, and trace elements [4]. The polysaccharides in the fruiting bodies, spores, mycelia, and fermentation liquors are particularly important. Their composition and molecular weight influence their properties, which vary from 8 × 103 to 6 × 106 Da. The composition depends on the extraction method, with sugars such as fucose, galactose, xylose, mannose, glucose, and glucuronic acid involved [51]. Different extraction techniques are used depending on the desired application of the extract [4,52]. For instance, hot water extraction of the fruiting body results in mannose with (1→2)- and (1→4)-linked structures, as well as (1→3)-linked glucans. The mycelium, in contrast, contains mannose, rhamnose, glucuronic acid, and glucose in various ratios.
Additionally, polysaccharides from Tremella fuciformis include xylose, mannose, and glucuronic acid linked by α-1,3-glycosidic bonds, with side chains of galactose, arabinose, and trace amounts of fucose [21]. The extract also has a significant amount of uronic acid (mainly glucuronic acid) and hydroxyl groups, which help maintain its stability over time, preserving its physical and chemical properties like electrical conductivity and pH [51]. Polysaccharides are classified into five types: acidic polysaccharides, neutral polysaccharides, acidic oligosaccharides, and cell wall polysaccharides [53]. Studies suggest that the viscosity of these polysaccharides plays a critical role in their biological activity, affecting their function in the body [54,55].
Based on this evidence, the following study set itself the goal of chemically and physically characterising a polysaccharide extract obtained from Tremella fuciformis to assess whether it was a type of extract that could be traced back to hyaluronic acid. Extraction of HA from solid tissues involves several steps: digestion (protease), boiling (denatured enzyme), centrifugation, extraction with chloroform, centrifugation, dialysis, precipitation with ethanol, centrifugation, redissolving, digestion, and boiling for denaturation of the enzyme. In addition, HA extraction techniques use detergents, enzymes, and/or solvents to break down the structure and isolate polysaccharide complexes from the tissue. These techniques depend on the chemical hydrolysis of the tissue, resulting in the breakdown of the proteoglycan core [16]. The extraction method proposed in this study does not incorporate a centrifugation step. Instead, an ethanol removal and pasteurisation step was performed after the ethanol and water precipitation step. This approach yielded a polysaccharide extract that exhibited comparable properties to hyaluronic acid, a result that is not attainable through conventional extraction methodologies. Notably, Tremella fuciformis extract has been utilised as a natural substitute for hyaluronic acid. However, these properties were observed based on its physicochemical characteristics rather than its HA content, demonstrating superior effects compared to hyaluronic acid [20]. In the present study, the extraction process resulted in an almost totally pure HA extract from Tremella fuciformis, as will be discussed later. Indeed, on the chemical composition of the extract under scrutiny, the analysis revealed that the non-animal hyaluronic acid extract derived from Tremella fuciformis exhibited a marginally acidic pH (pH = 6.5), a property that is presumably attributable to the presence of acidic polysaccharides within the extract. This finding is analogous to the reported stability values of HA in aqueous solution. In the context of HA stability in aqueous solution at pH 7, it has been observed that the degradation rate increases exponentially with rising temperature. Conversely, an acidic pH environment has been shown to cleave the HA molecule, leading to the release of NAG [56]. In the present study, the stability of a non-animal HA molecule in solution at pH 6.5 was investigated by determining the presence of NAG. The data obtained demonstrated a reduced presence of NAG, significantly affecting the stability of the high molecular weight polymer.
Furthermore, a high amount of polysaccharides was observed in the non-animal hyaluronic acid (about 90.6%), showing a similar yield value to those reported in the literature (about 89.6%) [35]. Given the hypothesis that the subject extract is abundant in hyaluronic acid, this substance’s content was determined by a colorimetric technique. This analysis method agreed with the data obtained by HPLC analysis. Indeed, non-animal hyaluronic acid demonstrated an HA content of approximately 87.76%, a profile comparable to the published reference data (about 95%) [30], as well as the HPLC analysis that revealed the presence of HA, which was detected as the corresponding disaccharide ∆Di-HA generated by chondroitinase AC enzymatic hydrolysis of the Tremella fuciformis extract. The characterisation of this disaccharide was determined through comparative analysis with the reference standard ∆Di-HA, alongside the identification of protonated and sodium cations observed in its mass spectrometric profile.
These data confirm the presence of hyaluronic acid in the extract, suggesting the success of the extraction process. Furthermore, the analysis of NAG also showed the success of the extraction process, as it was almost non-existent (value of less than 1%). Finally, it is important to mention that the characterisation of the non-animal hyaluronic acid content confirmed the presence of hyaluronic acid by assessing the molecular weight distribution and particle size. This finding corroborates the data reported in the extant literature (higher molecular weight over 2000 kDa) in which the polysaccharides are likened to hyaluronic acid for its application in the food, pharmaceutical, and cosmetic industries [30,57].
In addition, the data obtained by analysing the metal screening, sodium, and water content supported previous data on the presence of hyaluronic acid, excluding its salt (sodium hyaluronate); indeed, water content was about 7.6%, while sodium content was less than 2% (about 1.77%). Regarding the metal levels, the metals proved to be below the limit for human use, confirming the extraction process’s safety.
Further tests were performed to confirm the composition of non-animal hyaluronic acid. Related to NMR analysis, the natural abundance of 13C in non-animal hyaluronic acid revealed that the spectrum was compatible with HA structure, as reported in the literature [41,46,47]. In addition, the ATR-FTIR spectrum showed some differences in relative intensities (correlated with possible differences in chain length and sample granulometry). Still, the peaks identified in non-animal hyaluronic acid were similar to what was observed in the literature, thus confirming its identity [44].
Furthermore, non-animal hyaluronic acid has a molecular weight of over 2000 kDa; in this case, the direct analysis by MALDI mass spectrometry is complicated by the presence of short fragments ionisation. The MALDI-TOF analysis incorporated Tremella fuciformis powder, the extract after the first step of the extraction process, and the final non-animal hyaluronic acid to assess disparities in polysaccharides. A detailed observation of the MALDI-TOF spectra revealed discrepancies in the peak population. The YEF (YEF powder) sample had more peaks than the YET (initial stage of the extraction process). The visible difference in molecular weight between high-intensity peaks was 162 Da, corresponding to one glucan unit and consistent with the b-(1 3)-glucan repetition unit [49,58]. Based on the data obtained, it can be stated that there has been a progressive and marked reduction in the number of peaks from raw material (YEF powder) to non-animal hyaluronic acid, which is observable in molecular weight between the high-intensity peaks corresponding to one unit of sugar, in particular glucan. This demonstrates the correct extraction and purification procedure to obtain non-animal hyaluronic acid.
In conclusion, this comprehensive chemical and physical characterisation of Tremella fuciformis significantly enhances our prior investigations regarding its advantages for joint and dermal health. By systematically analysing its chemical and physical attributes, we aim to substantiate further the burgeoning evidence concerning Tremella’s efficacy as a supplement to enhance overall well-being. This research advances our comprehension of its potential, bridging the divide between its biological effects and practical applications in health maintenance.

5. Conclusions

In conclusion, the non-animal hyaluronic acid extract from Tremella fuciformis (GreenIuronic®) under consideration in this study has proven to be a promising source of hyaluronic acid or structurally similar polysaccharides with significant potential in the cosmetic and pharmaceutical industries. Preliminary chemical and physical analyses have confirmed the presence of bioactive components, including hyaluronic acid, within the extract. Even though preliminary stability analyses of the extract have been conducted and documented in Appendix B (see Table A4), further research is required to substantiate this stability and determine its efficacy over extended periods of utilisation. Furthermore, molecular characteristics, including the molecular weight and composition of sugar, have been determined to be crucial for the functional properties of the extract, suggesting that careful selection of the extraction method can optimise its benefits. Notwithstanding the positive results demonstrated in this study, several significant issues must be considered in future research aimed at improving the characterisation of Tremella fuciformis extract and verifying further applications in the cosmetic and pharmaceutical sectors. The characterisation of the extract will be further investigated, including possible variations in the chemical composition and functional properties of the extract in response to different cultivation and extraction parameters.

Author Contributions

Conceptualisation, R.G. and F.U.; methodology, S.M., S.F., F.P., A.G., I.M., G.P. and G.B.G.; software, R.G., S.M., S.F., F.P., A.G., M.C., I.M., G.P. and G.B.G.; validation, A.G., M.C., I.M., G.P., G.B.G. and F.U.; formal analysis, R.G., S.M., S.F., A.G., G.P. and G.B.G.; investigation, R.G.; resources, F.U.; data curation, R.G., F.U., I.M., M.C., G.P. and G.B.G.; writing—original draft preparation, R.G., S.M., S.F., F.P., A.G., M.C., I.M., G.P., G.B.G., L.M., C.M. and F.U.; visualisation, M.C., I.M., G.P., G.B.G., L.M., C.M. and F.U.; supervision, F.U.; project administration, F.U.; funding acquisition, F.U. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

The Laboratory of Physiology (F.Uberti) collects raw data and takes appropriate procedures to preserve them in a secure system forever. The corresponding author can provide this study’s data upon reasonable request.

Acknowledgments

The authors thank Vivatis Pharma GBHE for donating the substances used in this project. This study is part of the NODES project, which received funding from the MUR–M4C21.5 of the PNNR under grant agreement number ECS00000036.

Conflicts of Interest

The authors declare no conflicts of interest. F.U. is a co-founder of noivita Srls, and R.G. is an employee of noivita Srls, a Spin-Off of the University of Eastern Piedmont (UPO) that offers technical services. The Spin-Off has not influenced the outcome of this work. The remaining authors declare that the research was conducted without commercial or financial relationships that could be construed as potential conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
TFPSpolysaccharide of Tremella fuciformis
HPLChigh-performance liquid chromatography
HPLC-UVhigh-performance liquid chromatography-ultraviolet
HPLC-HRMShigh-resolution mass spectrometry
UVultraviolet spectroscopy
IRinfrared spectroscopy
ATRattenuated total reflectance
GCgas chromatography
MSmass spectrometry
NMRnuclear magnetic resonance
GalNAcacetylgalactosamine
NAGN-acetylglucosamine
USPUnited States Pharmacopeia
HAhyaluronic acid
D2Odeuterium oxide
FTIRFourier transform infrared spectroscopy
MALDI-TOFmatrix-assisted laser desorption/ionisation time-of-flight

Appendix A

Table A1. Gradient elution program.
Table A1. Gradient elution program.
Time (min)Mobile Phase B%
0.0020
7.0065
12.0065
12.5020
22.5020
Table A2. Gradient elution program implemented.
Table A2. Gradient elution program implemented.
Time (min)Mobile Phase B%
0.0020
4.0065
9.5065
10.0020
1520

Appendix B

Table A3. Peaks list of representative MALDI-TOF spectra in the 300–5000 m/z region. The abbreviations include the following: YET = extract of non-animal hyaluronic acid before extraction; YEF = intermediate extract of non-animal hyaluronic acid; non-animal HA = non-animal hyaluronic acid.
Table A3. Peaks list of representative MALDI-TOF spectra in the 300–5000 m/z region. The abbreviations include the following: YET = extract of non-animal hyaluronic acid before extraction; YEF = intermediate extract of non-animal hyaluronic acid; non-animal HA = non-animal hyaluronic acid.
Non-Animal HAYETYEF
m/zm/zm/z
312.697381.001381.103
330.624454.668459.885
374.738458.837464.996
462.842464.888478.402
510.252478.390524.831
532.431482.196543.104
543.860495.822559.075
565.865502.348581.223
571.893517.972598.114
580.831525.960614.146
587.856543.142636.220
593.898565.258675.538
598.787582.102687.308
603.820613.764705.572
609.718620.098713.488
719.971668.689751.652
770.132688.092765.576
902.166705.114779.085
924.212778.659785.838
945.997833.094796.461
1122.485850.682806.889
867.190823.238
1029.267849.652
1175.314867.906
1191.309995.427
1337.3601011.832
1353.3161030.180
1499.3631157.125
1515.3471174.062
1661.2971192.391
1677.2921319.139
1823.2701336.227
1839.7861354.493
1984.8271481.139
2001.7611498.332
2146.8141516.549
2163.7151643.134
2309.0451660.513
2325.6511678.650
2471.0001805.220
2487.0981822.475
2633.2361840.685
2649.0241967.455
2794.8321984.535
2811.1272002.688
2956.6192129.519
2972.9002146.446
3118.9152164.699
3135.2612291.634
3280.8302308.450
3296.7152326.695
3442.6202452.915
3459.1692470.398
3604.5032488.697
3620.7502615.662
3766.3992632.355
3782.4062650.580
3928.0112777.754
3944.5842794.233
4090.1392812.479
4105.9152921.118
4267.3712939.020
2956.096
2974.430
3101.218
3118.087
3136.289
3262.422
3280.065
3298.096
3424.925
3441.606
3460.027
3586.663
3603.239
3622.009
3765.512
3783.517
3926.940
3945.246
4088.691
4107.305
4251.836
4269.047
4412.032
4430.799
4592.707
4735.711
4753.176
4915.806
Table A4. Data related to HA content are expressed as % w/w ± SD (analyses performed every two months for one year).
Table A4. Data related to HA content are expressed as % w/w ± SD (analyses performed every two months for one year).
Non-Animal HAMay 2023August 2023November 2023February 2024May 2024
HA content92.0%91.2%91.2%88.2%87.8%

References

  1. Dhanapal, D.; Rajoo, B. Value addition of mushrooms by incorporation in the food products: An overview. Int. J. Food Eng. 2023, 19, 573–591. [Google Scholar] [CrossRef]
  2. Erbiai, E.H.; da Silva, L.P.; Saidi, R.; Lamrani, Z.; Esteves da Silva, J.C.G.; Maouni, A. Chemical Composition, Bioactive Compounds, and Antioxidant Activity of Two Wild Edible Mushrooms. Biomolecules 2021, 11, 575. [Google Scholar] [CrossRef] [PubMed]
  3. Kumar, K.; Mehra, R.; Guiné, R.P.F.; Lima, M.J.; Kumar, N.; Kaushik, R.; Ahmed, N.; Yadav, A.N.; Kumar, H. Edible Mushrooms: A Comprehensive Review on Bioactive Compounds with Health Benefits and Processing Aspects. Foods 2021, 10, 2996. [Google Scholar] [CrossRef] [PubMed]
  4. Yang, D.; Liu, Y.; Zhang, L. Tremella polysaccharide: The molecular mechanisms of its drug action. Prog. Mol. Biol. Transl. Sci. 2019, 163, 383–421. [Google Scholar] [CrossRef]
  5. Elkhateeb, W.A.; Daba, G.M. Review: The endless nutritional and pharmaceutical benefits of the Himalayan gold, Cordyceps; Current knowledge and prospective potentials. Biofarmasi J. Nat. Prod. Biochem. 2020, 18, 74–81. [Google Scholar] [CrossRef]
  6. Newman, D.J.; Cragg, G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016, 79, 629–661. [Google Scholar] [CrossRef]
  7. Wu, Y.; Shan, L.; Yang, S.; Ma, A. Identification and antioxidant activity of melanin isolated from Hypoxylon archeri, a companion fungus of Tremella fuciformis. J. Basic. Microbiol. 2008, 48, 217–221. [Google Scholar] [CrossRef]
  8. Li, X.; Wang, L.; Tan, B.; Li, R. Effect of structural characteristics on the physicochemical properties and functional activities of dietary fiber: A review of structure-activity relationship. Int. J. Biol. Macromol. 2024, 269 Pt 2, 132214. [Google Scholar] [CrossRef]
  9. Prashanth, K.H.; Tharanathan, R.N. Chitin/chitosan: Modifications and their unlimited application potential—An overview. Trends Food Sci. Technol. 2007, 18, 117–131. [Google Scholar] [CrossRef]
  10. Chaidedgumjorn, A.; Toyoda, H.; Woo, E.R.; Lee, K.B.; Kim, Y.S.; Toida, T.; Imanari, T. Effect of (1→ 3)-and (1→ 4)-linkages of fully sulfated polysaccharides on their anticoagulant activity. Carbohydr. Res. 2002, 337, 925–933. [Google Scholar] [CrossRef]
  11. Lin, C.P.; Tsai, S.Y. Differences in the Moisture Capacity and Thermal Stability of Tremella fuciformis Polysaccharides Obtained by Various Drying Processes. Molecules 2019, 24, 2856. [Google Scholar] [CrossRef] [PubMed]
  12. Tsai, S.-Y.; Hwang, B.-F.; Wang, Y.-H.; Lin, C.-P. Moisture desorption and thermal properties of polysaccharide from pulsed light irradiated Flammulina velutipes. J. Therm. Anal. Calorim. 2016, 127, 469–481. [Google Scholar] [CrossRef]
  13. Lin, H.Y.; Tsai, S.Y.; Yu, H.T.; Lin, C.P. Degradation of Polylactic Acid by Irradiation. J. Polym. Environ. 2018, 26, 122–131. [Google Scholar] [CrossRef]
  14. Fang, Y.; Zhang, Q.; Yu, C.; Xu, X.; Lei, P.; Xu, H.; Li, S. In vitro digestion and fecal fermentation of Tremella fuciformis exopolysaccharides from basidio-spore-derived submerged fermentation. Food Res. Int. 2024, 196, 115019. [Google Scholar] [CrossRef]
  15. Ge, X.; Huang, W.; Xu, X.; Lei, P.; Sun, D.; Xu, H.; Li, S. Production, structure, and bioactivity of polysaccharide isolated from Tremella fuciformis XY. Int. J. Biol. Macromol. 2020, 148, 173–181. [Google Scholar] [CrossRef]
  16. Graciela, C.-Q.; José Juan, E.-C.; Gieraldin, C.-L.; Xóchitl Alejandra, P.-M.; Gabriel, A.-Á. Hyaluronic Acid—Extraction Methods, Sources and Applications. Polymers 2023, 15, 3473. [Google Scholar] [CrossRef]
  17. Wu, Q.; Dai, Y.G.; Zou, X.F.; Chen, L.N.; Zhang, L.H.; Gao, C.C.; Chen, X. Isolation of alkai-soluble polysaccharide from Tremella Fuciformis and its antioxidant activity in vitro. In Proceedings of the 2011 IEEE International Symposium on IT in Medicine and Education, Guangzhou, China, 9–11 December 2011; IEEE: Tenbury Wells, UK, 2011; Volume 2, pp. 711–714. [Google Scholar]
  18. Wu, Y.J.; Wei, Z.X.; Zhang, F.M.; Linhardt, R.J.; Sun, P.L.; Zhang, A.Q. Structure, bioactivities and applications of the polysaccharides from Tremella fuciformis mushroom: A review. Int. J. Biol. Macromol. 2019, 121, 1005–1010. [Google Scholar] [CrossRef]
  19. Tian, L.; Roos, Y.H.; Gómez-Mascaraque, L.G.; Lu, X.; Miao, S. Tremella fu-ciformis Polysaccharides: Extraction, Physicochemical, and Emulsion Properties at Different pHs. Polymers 2023, 15, 1771. [Google Scholar] [CrossRef]
  20. Woźniak, B.; Chudzińska, J.; Szczyglewska, P.; Nowak, I.; Feliczak-Guzik, A. Optimisation of the Composition of a Cosmetic Formulation Containing Tremella fuciformis Extract (Fungi). Cosmetics 2023, 10, 82. [Google Scholar] [CrossRef]
  21. Ma, X.; Yang, M.; He, Y.; Zhai, C.; Li, C. A review on the production, structure, bioactivities and applications of Tremella polysaccharides. Int. J. Immunopathol. Pharmacol. 2021, 35, 20587384211000541. [Google Scholar] [CrossRef]
  22. Yan, Y.; Wang, M.; Chen, N.; Wang, X.; Fu, C.; Li, Y.; Gan, X.; Lv, P.; Zhang, Y. Isolation, structures, bioactivities, application and future prospective for polysaccharides from. Front. Immunol. 2022, 13, 1091210. [Google Scholar] [CrossRef] [PubMed]
  23. Ma, X.; Yang, M.; He, Y.; Shao, L. A Method of Extracting Tremella Polysaccharides from Fermentation Liquid. Chinese Patent CN109836511A, 4 June 2019. [Google Scholar]
  24. Chen, G.; Bu, F.; Chen, X.; Li, C.; Wang, S.; Kan, J. Ultrasonic extraction, structural characterization, physicochemical properties and antioxidant activities of polysaccharides from bamboo shoots (Chimonobambusa quadrangularis) processing by-products. Int. J. Biol. Macromol. 2018, 112, 656–666. [Google Scholar] [CrossRef] [PubMed]
  25. Chen, B. Optimization of extraction of Tremella fuciformis polysaccharides and its antioxidant and antitumour activities in vitro. Carbohydr. Polym. 2010, 81, 420–424. [Google Scholar] [CrossRef]
  26. Chen, Y.; Zhao, L.; Liu, B.; Zuo, S. Application of response surface methodology to optimise microwave-assisted extraction of polysaccharide from Tremella. Phys. Procedia 2012, 24, 429–433. [Google Scholar] [CrossRef]
  27. Zou, Y.; Hou, X. Extraction optimisation, composition analysis, and antioxi-dation evaluation of polysaccharides from white jelly mushroom, Tremella fuciformis (Tremellomycetes). Int. J. Med. Mushrooms 2017, 19, 1113–1121. [Google Scholar] [CrossRef]
  28. Li, Y.; Xu, F.; Zheng, M.; Xi, X.; Cui, X.; Han, C. Maca polysaccharides: A review of compositions, isolation, therapeutics and prospects. Int. J. Biol. Macromol. 2018, 111, 894–902. [Google Scholar] [CrossRef]
  29. Liu, J.; Zhao, Y.; Wu, Q.; John, A.; Jiang, Y.; Yang, J.; Liu, H.; Yang, B. Structure characterisation of polysaccharides in vegetable “okra” and evaluation of hypoglycemic activity. Food Chem. 2018, 242, 211–216. [Google Scholar] [CrossRef]
  30. Galla, R.; Ruga, S.; Aprile, S.; Ferrari, S.; Brovero, A.; Grosa, G.; Molinari, C.; Uberti, F. New Hyaluronic Acid from Plant Origin to Improve Joint Protection-An In Vitro Study. Int. J. Mol. Sci. 2020, 23, 8114. [Google Scholar] [CrossRef]
  31. Vivatis Pharma GMBH. Plant Producing Hyaluronic Acid. Italian Patent PCT/IB2021/055031, 8 June 2020. [Google Scholar]
  32. Identification and Selection of a Plant Starting Material of a Plant Chondroitin Sulfate and Hyaluronic Acid, and Transformation of such Plant Starting Material to Obtain Ingredients for Use in Foods, Supple-Ments, Medical Devices or Drugs. Italian Patent 102019000008409, 8 June 2021.
  33. Jiménez, P.C.; Montenegro, O.; Sosa, R.J.; Torre, J.D.; Acosta, J.; Pérez, D.L.; Rodríguez, A.; Méndez, R.R.; Alonso, A.C.; Corrales, A.; et al. Total carbohydrates concentration evaluation in products of microbial origin. Afinidad 2019, 76, 195–203. [Google Scholar]
  34. Blumenkrantz, N.; Asboe-Hansen, G. New method for quantitative determination of uronic acids. Anal. Biochem. 1973, 54, 484–489. [Google Scholar] [CrossRef]
  35. Majewski, G.P.; Rodan, K.; Fields, K.; Falla, T.J. Characterization of bound water in skin hydrators prepared with and without a 3D3P interpenetrating polymer network. Skin. Res. Technol. 2019, 25, 150–157. [Google Scholar] [CrossRef]
  36. Kim, H.J.; Bae, I.K.; Jeong, M.H.; Park, H.J.; Jung, J.S.; Kim, J.E. A New HPLC-ELSD Method for Simultaneous Determination of N-Acetylglucosamine and N-Acetylgalactosamine in Dairy Foods. Int. J. Anal. Chem. 2015, 2015, 892486. [Google Scholar] [CrossRef] [PubMed]
  37. 233 ELEMENTAL IMPURITIES—PROCEDURES. Available online: https://www.usp.org/sites/default/files/usp/document/our-work/chemical-medicines/key-issues/c233.pdf (accessed on 7 September 2024).
  38. Lee, H.G.; Cowman, M.K. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal. Biochem. 1994, 219, 278–287. [Google Scholar] [CrossRef] [PubMed]
  39. USP 791 pH EVALUATION—PROCEDURES. Available online: http://www.uspbpep.com/usp29/v29240/usp29nf24s0_c791.html (accessed on 7 September 2024).
  40. Paul, G.; Steuernagel, S.; Koller, H. Non-covalent interactions of a drug molecule encapsulated in a hybrid silica gel. Chem. Comm. 2007, 5194–5196. [Google Scholar] [CrossRef]
  41. López-García, M.; García, M.S.; Vilariño, J.M.; Rodríguez, M.V. MALDI-TOF to compare polysaccharide profiles from commercial health supplements of different mushroom species. Food Chem. 2016, 199, 597–604. [Google Scholar] [CrossRef]
  42. Gitsomboon, S.; Ratanapornsompong, G.; Ongphiphadhanakul, B.; Thongpradit, S.; Chanprasertyothin, S.; Chailurtkit, L.O.; Nimitphong, H. Tremella fuciformis beverage improves glycated hemoglobin A1c and waist circumference in overweight/obese prediabetic subjects: A randomized controlled trial. BMC Nutr. 2024, 10, 44. [Google Scholar] [CrossRef]
  43. Li, Y.; Chen, J.; Lai, P.; Tang, B.; Wu, L. Influence of drying methods on the physicochemical properties and nutritional composition of instant Tremella fuciform-is. Food Sci. Technol. 2020, 40. [Google Scholar] [CrossRef]
  44. Rampratap, P.; Lasorsa, A.; Perrone, B.; van der Wel, P.C.A.; Walvoort, M.T.C. Production of isotopically enriched high molecular weight hyaluronic acid and characterization by solid-state NMR. Carbohydr. Polym. 2023, 316, 121063. [Google Scholar] [CrossRef]
  45. Forgács, A.; Papp, V.; Paul, G.; Marchese, L.; Len, A.; Dudás, Z.; Fábián, I.; Gurikov, P.; Kalmár, J. Mechanism of hydration and hydration induced structural changes of calcium alginate aerogel. ACS Appl. Mater. Interfaces 2021, 13, 2997–3010. [Google Scholar] [CrossRef]
  46. Pouyani, T.; Harbison, G.S.; Prestwich, G.D. Novel Hydrogels of Hyaluronic Acid: Synthesis, Surface Morphology, and Solid-State NMR. J. Am. Chem. Soc. 1994, 116, 7515–7522. [Google Scholar] [CrossRef]
  47. Grosu, I.-G.; Mot, A.; Filip, X.; Filip, C. What Is Wrong with Hyaluronic Acid Chemistry? A 15N/13C Solid-State NMR Re-Evaluation of Its Dopamine Conjugates. Polymers 2023, 15, 2825. [Google Scholar] [CrossRef] [PubMed]
  48. Pan, N.C.; Pereira, H.C.B.; da Silva, M.L.C.; Vasconcelos, A.F.D.; Celligoi, M.A.P.C. Improvement Production of Hyaluronic Acid by Streptococcus zooepidemicus in Sugarcane Molasses. Appl. Biochem. Biotechnol. 2017, 182, 276–293. [Google Scholar] [CrossRef] [PubMed]
  49. Manju, S.; Sreenivasan, K. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J. Colloid Interface Sci. 2011, 359, 318–325. [Google Scholar] [CrossRef] [PubMed]
  50. Wu, Y. Preparation of low-molecular-weight hyaluronic acid by ozone treatment. Carbohydr. Polym. 2012, 89, 709–712. [Google Scholar] [CrossRef]
  51. Yang, M.; Zhang, Z.; He, Y.; Li, C.; Wang, J.; Ma, X. Study on the structure characterization and moisturizing effect of Tremella polysaccharide fermented from GCMCC5.39. Food Sci. Hum. Wellness 2021, 10, 471–479. [Google Scholar] [CrossRef]
  52. Hui, L. Comparison of the Moisture Retention Capacity of Tremella Polysaccharides and Hyaluronic Acid. J. Anhui Agric. Sci. 2012, 40, 13093–13094. [Google Scholar]
  53. Zhang, Y.Z.; Zhang, Q.; Lu, J.; Xu, J.L.; Zhang, H.; Jun-Hui, W. Physicochemical properties of Tremella fuciformis polysaccharide and its interactions with myofibrillar protein. Bioact. Carbohydr. Diet. Fibre 2017, 11, 18–25. [Google Scholar] [CrossRef]
  54. Dickinson, E. Mixed biopolymers at interfaces: Competitive adsorption and multilayer structures. Food Hydrocoll. 2011, 25, 1966–1983. [Google Scholar] [CrossRef]
  55. Schmitt, C.; Turgeon, S.L. Protein/polysaccharide complexes and coacervates in food systems. Adv. Colloid Interface Sci. 2011, 167, 63–70. [Google Scholar] [CrossRef]
  56. Buffa, R.; Klejch, T.; Hermannová, M.; Hejlová, L.; Svozil, V.; Vágnerová, H.; Škubalová, H.; Nešporová, K.; Velebný, V. Modified hyaluronic acid with enhanced resistance to degradation. Carbohydr. Polym. 2023, 320, 121241. [Google Scholar] [CrossRef]
  57. Yuan, H.; Dong, L.; Zhang, Z.; He, Y.; Ma, X. Production, structure, and bioactivity of polysaccharide isolated from Tremella fuciformis. Food Sci. Hum. Well 2022, 11, 1010–1017. [Google Scholar] [CrossRef]
  58. Thomas, F.; Le Duff, N.; Leroux, C.; Dartevelle, L.; Riera, P. Isotopic labeling of cultured macroalgae and isolation of 13C-labeled cell wall polysaccharides for trophic investigations. Adv. Bot. Res. 2020, 95, 1–17. [Google Scholar]
Figure 1. Flowchart of key points of the non-animal hyaluronic acid extraction process [31].
Figure 1. Flowchart of key points of the non-animal hyaluronic acid extraction process [31].
Foods 14 01362 g001
Figure 2. Analysis of molecular weight of non-animal hyaluronic acid. In (A), an example of 1% agarose gel. The sample loads are described by the following abbreviations: L1 = standard molecular weight HiLadder specific for HA detection; L2 = lane loaded with 3 mg/mL reference published [30]; L3 = lane loaded with 3 mg/mL non-animal hyaluronic acid extract. In (B), the chromatogram is obtained from the particle size distribution.
Figure 2. Analysis of molecular weight of non-animal hyaluronic acid. In (A), an example of 1% agarose gel. The sample loads are described by the following abbreviations: L1 = standard molecular weight HiLadder specific for HA detection; L2 = lane loaded with 3 mg/mL reference published [30]; L3 = lane loaded with 3 mg/mL non-animal hyaluronic acid extract. In (B), the chromatogram is obtained from the particle size distribution.
Foods 14 01362 g002
Figure 3. HPLC-UV and HRMS analysis of non-animal hyaluronic acid after enzymatic hydrolysis with chondroitinase AC. In (A), HPLC-UV chromatogram of non-animal hyaluronic acid sample and its positive HRMS spectrum. In (B), HPLC-UV chromatograms of a mixture of chondroitin disaccharides standard ΔDi-0S, ΔDi-4S, and ΔDi-6S, and in (C), a solution of the disaccharide standard ΔDi-HA of HA.
Figure 3. HPLC-UV and HRMS analysis of non-animal hyaluronic acid after enzymatic hydrolysis with chondroitinase AC. In (A), HPLC-UV chromatogram of non-animal hyaluronic acid sample and its positive HRMS spectrum. In (B), HPLC-UV chromatograms of a mixture of chondroitin disaccharides standard ΔDi-0S, ΔDi-4S, and ΔDi-6S, and in (C), a solution of the disaccharide standard ΔDi-HA of HA.
Foods 14 01362 g003
Figure 4. 13C CPMAS NMR spectrum of non-animal hyaluronic acid recorded using a MAS rate of 11 kHz and a CP contact time of 0.5 ms. Inset (right) shows the 1H MAS NMR spectrum of non-animal hyaluronic acid recorded using an MAS rate of 15 kHz. Inset (left) shows the molecular structure of hyaluronic acid.
Figure 4. 13C CPMAS NMR spectrum of non-animal hyaluronic acid recorded using a MAS rate of 11 kHz and a CP contact time of 0.5 ms. Inset (right) shows the 1H MAS NMR spectrum of non-animal hyaluronic acid recorded using an MAS rate of 15 kHz. Inset (left) shows the molecular structure of hyaluronic acid.
Foods 14 01362 g004
Figure 5. ATR-FTIR spectrum of non-animal hyaluronic acid (curve a, black) and standard hyaluronic acid (curve b, blue).
Figure 5. ATR-FTIR spectrum of non-animal hyaluronic acid (curve a, black) and standard hyaluronic acid (curve b, blue).
Foods 14 01362 g005
Figure 6. Representative MALDI-TOF mass spectra in the 300–5000 m/z region. The abbreviations include the following: YET = extract of non-animal hyaluronic acid before extraction; YEF = intermediate extract of non-animal hyaluronic acid; non-animal HA = non-animal hyaluronic acid.
Figure 6. Representative MALDI-TOF mass spectra in the 300–5000 m/z region. The abbreviations include the following: YET = extract of non-animal hyaluronic acid before extraction; YEF = intermediate extract of non-animal hyaluronic acid; non-animal HA = non-animal hyaluronic acid.
Foods 14 01362 g006
Table 1. Data related to total polysaccharides, HA, uronic, NAG, and water content are expressed as % w/w ± SD. For all analyses, three independent experiments were carried out in quadruplicate. I.M. = internal method; F.K.W.C = Karl Fisher water content.
Table 1. Data related to total polysaccharides, HA, uronic, NAG, and water content are expressed as % w/w ± SD. For all analyses, three independent experiments were carried out in quadruplicate. I.M. = internal method; F.K.W.C = Karl Fisher water content.
AnalysisValueUnit of Measure
Total polysaccharides (I.M.)90.6% (w/w)
Total Hyaluronic Acid (I.M.)87.8% (w/w)
Uronic content (I.M.)2.39% (w/w)
NAG content (I.M.)<0.1% (w/w)
Water Content (F.K.W.C.)7.6% (w/w)
Table 2. Metals analysis performed on USP 233. For all analyses, three independent experiments were carried out in quadruplicate. The indicated measurement uncertainty corresponds to the expanded uncertainty with coverage factor k = 2 at a probability level p = 95%. The laboratory does not correct the analytical results for the recovery factor. The decision rules adopted for the expression of conformity (if any) do not consider the associated uncertainty contribution unless specifically requested by the customer to take it into account or specifically required by the relevant legislation or regulation. When preceded by the symbol “<”, the result refers to the lower limit of quantification of the applied method.
Table 2. Metals analysis performed on USP 233. For all analyses, three independent experiments were carried out in quadruplicate. The indicated measurement uncertainty corresponds to the expanded uncertainty with coverage factor k = 2 at a probability level p = 95%. The laboratory does not correct the analytical results for the recovery factor. The decision rules adopted for the expression of conformity (if any) do not consider the associated uncertainty contribution unless specifically requested by the customer to take it into account or specifically required by the relevant legislation or regulation. When preceded by the symbol “<”, the result refers to the lower limit of quantification of the applied method.
AnalysisValueUnit of Measure
Arsenic (USP <233>)<0.5ppm
Cadmium (USP <233>)<0.5ppm
Cobalt (USP <233>)<0.5ppm
Chromium (USP <233>)0.88ppm
Iron (USP <233>)9.76ppm
Magnesium (USP <233>)99.8ppm
Manganese (USP <233>)1.16ppm
Mercury (USP <233>)<0.2ppm
Nichel (USP <233>)<0.5ppm
Lead (USP <233>)<0.5ppm
Copper (USP <233>)<0.5ppm
Selenium (USP <233>)<1ppm
Tin (USP <233>)<0.5ppm
Zinc (USP <233>)<0.5ppm
Sodium (USP <233>)1.77% (w/w)
Table 3. pH analysis. The value is a pH unit of three independent experiments carried out in quadruplicate.
Table 3. pH analysis. The value is a pH unit of three independent experiments carried out in quadruplicate.
AnalysisValueUnit of Measure
pH (USP <791>)6.5Unit of pH
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Galla, R.; Mulè, S.; Ferrari, S.; Parini, F.; Givonetti, A.; Cavaletto, M.; Miletto, I.; Paul, G.; Giovenzana, G.B.; Marchese, L.; et al. Non-Animal Hyaluronic Acid from Tremella fuciformis: A New Source with a Structure and Chemical Profile Comparable to Hyaluronic Acid. Foods 2025, 14, 1362. https://doi.org/10.3390/foods14081362

AMA Style

Galla R, Mulè S, Ferrari S, Parini F, Givonetti A, Cavaletto M, Miletto I, Paul G, Giovenzana GB, Marchese L, et al. Non-Animal Hyaluronic Acid from Tremella fuciformis: A New Source with a Structure and Chemical Profile Comparable to Hyaluronic Acid. Foods. 2025; 14(8):1362. https://doi.org/10.3390/foods14081362

Chicago/Turabian Style

Galla, Rebecca, Simone Mulè, Sara Ferrari, Francesca Parini, Annalisa Givonetti, Maria Cavaletto, Ivana Miletto, Geo Paul, Giovanni Battista Giovenzana, Leonardo Marchese, and et al. 2025. "Non-Animal Hyaluronic Acid from Tremella fuciformis: A New Source with a Structure and Chemical Profile Comparable to Hyaluronic Acid" Foods 14, no. 8: 1362. https://doi.org/10.3390/foods14081362

APA Style

Galla, R., Mulè, S., Ferrari, S., Parini, F., Givonetti, A., Cavaletto, M., Miletto, I., Paul, G., Giovenzana, G. B., Marchese, L., Molinari, C., & Uberti, F. (2025). Non-Animal Hyaluronic Acid from Tremella fuciformis: A New Source with a Structure and Chemical Profile Comparable to Hyaluronic Acid. Foods, 14(8), 1362. https://doi.org/10.3390/foods14081362

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop